2023-10-01 2024-09-30 false Capium Accounts Production 1.1 14359806 bus:AbridgedAccounts 2023-10-01 2024-09-30 14359806 bus:FRS102 2023-10-01 2024-09-30 14359806 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 14359806 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 14359806 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 14359806 2023-10-01 2024-09-30 14359806 2024-09-30 14359806 bus:RegisteredOffice 2023-10-01 2024-09-30 14359806 core:WithinOneYear 2024-09-30 14359806 core:AfterOneYear 2024-09-30 14359806 bus:Director1 2023-10-01 2024-09-30 14359806 bus:Director1 2024-09-30 14359806 bus:Director1 2022-09-15 2023-09-30 14359806 2022-09-15 14359806 bus:LeadAgentIfApplicable 2023-10-01 2024-09-30 14359806 2022-09-15 2023-09-30 14359806 2023-09-30 14359806 core:WithinOneYear 2023-09-30 14359806 core:AfterOneYear 2023-09-30 14359806 bus:EntityAccountantsOrAuditors 2022-09-15 2023-09-30 14359806 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 14359806 bus:OrdinaryShareClass1 2024-09-30 14359806 bus:OrdinaryShareClass1 2022-09-15 2023-09-30 14359806 bus:OrdinaryShareClass1 2023-09-30 14359806 core:ComputerEquipment 2023-10-01 2024-09-30 14359806 core:ComputerEquipment 2024-09-30 14359806 core:ComputerEquipment 2023-09-30 14359806 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 14359806 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-09-30 14359806 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 14359806 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 14359806 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-09-30 14359806 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 14359806 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 14359806 core:Non-currentFinancialInstruments 2024-09-30 14359806 core:Non-currentFinancialInstruments 2023-09-30 14359806 core:ShareCapital 2024-09-30 14359806 core:ShareCapital 2023-09-30 14359806 core:RetainedEarningsAccumulatedLosses 2024-09-30 14359806 core:RetainedEarningsAccumulatedLosses 2023-09-30 14359806 dpl:Item1 2023-10-01 14359806 dpl:Item1 2024-09-30 14359806 dpl:Item1 2022-09-15 14359806 dpl:Item1 2023-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14359806
England and Wales

 

 

 

ZEE MEDICS LTD


Abridged Accounts
 


Period of accounts

Start date: 01 October 2023

End date: 30 September 2024
Report to the directors on the preparation of the unaudited statutory accounts of Zee Medics Ltd for the year ended 30 September 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Zee Medics Ltd for the year ended 30 September 2024 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/
This report is made solely to the Board of Directors of Zee Medics Ltd, as a body, in accordance with the terms of our engagement letter dated Our work has been undertaken solely to prepare for your approval the accounts of Zee Medics Ltd and state those matters that we have agreed to state to the Board of Directors of Zee Medics Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Zee Medics Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Zee Medics Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Zee Medics Ltd. You consider that Zee Medics Ltd is exempt from the statutory audit requirement for the year
We have not been instructed to carry out an audit or a review of the accounts of Zee Medics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
30 September 2024



....................................................
Secure Accounts Limited.
Suite 2A, 6 Floor
Cobalt Square, 83-85 Hagley Road
Birmingham
B16 8QG
08 October 2024
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 572    715 
572    715 
Current assets      
Cash at bank and in hand 87,633    63,347 
Creditors: amount falling due within one year (13,261)   (29,416)
Net current assets 74,372    33,931 
 
Total assets less current liabilities 74,944    34,646 
Net assets 74,944    34,646 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 74,844    34,546 
Shareholders' funds 74,944    34,646 
 


For the year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 08 October 2024 and were signed by:


-------------------------------
Nimra Shahid
Director
2
General Information
Zee Medics Ltd is a private company, limited by shares, registered in England and Wales, registration number 14359806, registration address 20 Academy Road, Birmingham, B38 9FG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 20% Reducing Balance
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 October 2023 894    894 
Additions  
Disposals  
At 30 September 2024 894    894 
Depreciation
At 01 October 2023 179    179 
Charge for year 143    143 
On disposals  
At 30 September 2024 322    322 
Net book values
Closing balance as at 30 September 2024 572    572 
Opening balance as at 01 October 2023 715    715 


4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

3